ML
Mark Landon Harvill
About Mark Landon Harvill
Data last updated:
Mark Landon Harvill is an Additional Director at Avance Clinical India Private Limited (since 2025). The company operates in Healthcare. Avance Clinical India Private Limited reported revenue of ₹9.35 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Avance Clinical India Private Limited U73100KA2022FTC167429 | Additional Director | 30 Jul 2025 | ₹9.35 Cr (FY 2025) | Active |
Board colleagues of Mark Landon Harvill
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gregory Charles Vella | 09776284 | Avance Clinical India Private Limited | Director |
| Yadehalli Gundurao Ramya | 10330968 | Avance Clinical India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mark Landon Harvill
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mark Landon Harvill
Mark Landon Harvill currently holds 1 directorship: Avance Clinical India Private Limited (Additional Director, since 30 Jul 2025, revenue ₹9.35 Cr (FY 2025)).
Mark Landon Harvill was first appointed on 30 Jul 2025 as Additional Director at Avance Clinical India Private Limited.
The current boards of Mark Landon Harvill's companies include Gregory Charles Vella (Avance Clinical India Private Limited), Yadehalli Gundurao Ramya (Avance Clinical India Private Limited).